Search

Search Constraints

You searched for: Issue Volume 138(2020)Supplement 1

Search Results

381. Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer. (October 2020)

383. Updated results of the MINDACT trial: 70-gene signature to guide de-escalation of chemotherapy in early breast cancer. (October 2020)

384. Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement for Aromatase Inhibitors-related Arthralgia Management (AIA): A prospective phase II trial (NCT04161833). (October 2020)

388. Use of oral complementary-alternative medicine (OCAM) and fatigue among early breast cancer (BC) patients (pts). (October 2020)